1. Home
  2. FTLF vs VTVT Comparison

FTLF vs VTVT Comparison

Compare FTLF & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

HOLD

Current Price

$9.31

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$31.26

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTLF
VTVT
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
148.7M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
FTLF
VTVT
Price
$9.31
$31.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$21.50
$53.00
AVG Volume (30 Days)
37.0K
51.6K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
$21,744,000.00
N/A
Revenue This Year
$45.76
N/A
Revenue Next Year
$5.10
N/A
P/E Ratio
$14.91
N/A
Revenue Growth
11.52
N/A
52 Week Low
$8.67
$14.00
52 Week High
$20.98
$44.00

Technical Indicators

Market Signals
Indicator
FTLF
VTVT
Relative Strength Index (RSI) 31.17 38.46
Support Level $8.67 $30.62
Resistance Level $15.34 $33.11
Average True Range (ATR) 0.57 2.84
MACD 0.15 -0.91
Stochastic Oscillator 45.45 17.78

Price Performance

Historical Comparison
FTLF
VTVT

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: